CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 1 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $136,000 | -42.1% | 122,249 | -10.5% | 0.00% | – |
| Q4 2021 | $235,000 | -71.9% | 136,609 | -49.9% | 0.00% | -100.0% |
| Q3 2021 | $837,000 | -42.8% | 272,554 | -27.4% | 0.00% | 0.0% |
| Q2 2021 | $1,464,000 | +666.5% | 375,260 | +448.0% | 0.00% | – |
| Q1 2021 | $191,000 | -65.6% | 68,472 | -62.2% | 0.00% | – |
| Q4 2020 | $555,000 | -6.4% | 181,287 | +85.8% | 0.00% | -100.0% |
| Q3 2020 | $593,000 | -29.6% | 97,545 | -31.5% | 0.00% | 0.0% |
| Q2 2020 | $842,000 | +264.5% | 142,458 | +63.6% | 0.00% | – |
| Q1 2020 | $231,000 | -68.9% | 87,096 | -68.1% | 0.00% | -100.0% |
| Q4 2019 | $742,000 | -44.3% | 272,783 | +148.1% | 0.00% | -50.0% |
| Q3 2019 | $1,332,000 | +6.1% | 109,935 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $1,255,000 | – | 109,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |